Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biodentine vs Xeno Graft for Socket Preservation
NCT06695208Phase 4Recruiting
- Sponsor
- Cairo University
- Start
- Dec 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms), sponsored by Cairo University. Primary endpoint: Radiographic assessment of bone width at 6 months. Started Dec 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06695208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06695208.